Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying the stock. We monitor 13F filings and institutional buying patterns because large investors often have superior information.
Celldex Therapeutics Inc. (CLDX) is trading at $31.35 as of 2026-04-07, posting a modest 0.06% dip in today’s session amid flat broader market trading for healthcare stocks. This analysis outlines key technical levels, prevailing market context, and potential short-term price scenarios for the clinical-stage biotech stock, with no recent earnings data available for the company as of publication. There are no confirmed, publicly disclosed pipeline or regulatory events scheduled for the near term
What are analysts saying about Celldex (CLDX) Stock | Price at $31.35, Down 0.06% - AI Powered Stock Picks
CLDX - Stock Analysis
4584 Comments
1068 Likes
1
Layna
Power User
2 hours ago
This feels like I just unlocked level confusion.
👍 26
Reply
2
Johnella
New Visitor
5 hours ago
Energy, skill, and creativity all in one.
👍 122
Reply
3
Ariellys
New Visitor
1 day ago
Simply outstanding!
👍 142
Reply
4
Sammul
Legendary User
1 day ago
No one could have done it better!
👍 275
Reply
5
Islam
Expert Member
2 days ago
Momentum appears intact, but minor corrections may occur.
👍 144
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.